摘要
In China, the prevalence of type 2 diabetes mellitus is increasing due to the aging of the population, increased frequency of obesity, and suboptimal nutritional habits. The current number of diabetic patients in China is around 40 million. Patients with diabetes even without prior cardiovascular disease have the same event rates as individuals without diabetes but with prior myocardial infarction, Diabetes is present in 25% of patients undergoing percutaneous coronary intervention （PCI）, and a more diffuse and accelerated form of atherosclerosis accompanied by smaller vessel size, longer lesions, and greater plaque burden in diabetic patients may contribute to the well-documented increased risk of neointimal hyperplasia and restenosis after stent implantation in these patients. Clinical as well as angiographic outcomes have been consistently worse for diabetics compared with non-diabetics.
In China, the prevalence of type 2 diabetes mellitus is increasing due to the aging of the population, increased frequency of obesity, and suboptimal nutritional habits. The current number of diabetic patients in China is around 40 million. Patients with diabetes even without prior cardiovascular disease have the same event rates as individuals without diabetes but with prior myocardial infarction, Diabetes is present in 25% of patients undergoing percutaneous coronary intervention （PCI）, and a more diffuse and accelerated form of atherosclerosis accompanied by smaller vessel size, longer lesions, and greater plaque burden in diabetic patients may contribute to the well-documented increased risk of neointimal hyperplasia and restenosis after stent implantation in these patients. Clinical as well as angiographic outcomes have been consistently worse for diabetics compared with non-diabetics.
